Skip to content

Effects of a high-fat and a low-fat diet on early biomarkers of metabolic stress in blood and gene expression in the small intestine of healthy subjects

Effects of a high-fat and a low-fat diet on early biomarkers of metabolic stress in blood and gene expression in the small intestine of healthy subjects - Effects of high-fat and low-fat diet on the gut

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31635
Enrollment
10
Registered
2007-10-15
Start date
2008-01-21
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

disturbed fat and glucose metabolism metabolic syndrome

Interventions

Subjects will consume in random order a) a HF diet (40 En% fat, 45 En% carbohydrates and 15 En% proteins) and b) a LF diet (20 En% fat, 65 En% carbohydrates and 15 En% proteins).

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age between 18 and 65 years body mass index (BMI) between 18 and 30 kg/m2

Exclusion criteria

Exclusion criteria: - BMI = 30 kg/m2 - Smoking - Serum Total cholesterol > 8.0 mmol/L - Fasting glucose > 7.0 mmol/L - Use of any medication - Active cardiovascular diseases like congestive heart failure or recent ( 3 kg in the past three months) - Impairment of renal function, as evidenced by increased serum creatinine >150 mmol/L - Hepatic diseases as manifested by ALT, AST, GGT, total bilirubin or ALP > 2 times the upper limit of normal - CRP values > 8.0 mg/mL - Abuse of drugs and/or alcohol - Participation in another biomedical study within 1 month prior to the start of this study - Having donated blood (as blood donor) within 1 month prior to start of this study

Design outcomes

Primary

MeasureTime frame
Potential early biomarkers of the metabolic syndrome in blood and gene expression profiles in the small intestine.

Secondary

MeasureTime frame
Parameters of the metabolic syndrome in blood, gene expression profiles in PBMC and gut permeability.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)